| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/23/2002 | US6423519 Contacting fungal cell with compound which inhibits prenyltransferase activity of cell, including permease tag which facilitates permease-mediated transport of compound into cell, inhibiting growth thereof |
| 07/23/2002 | US6423516 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 07/23/2002 | US6423500 Mammalian receptors for interleukin-10 |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/23/2002 | US6423318 Hepatitis A virus vaccines |
| 07/23/2002 | US6423308 Treatment of Kaposi's sarcoma with IL-12 |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2107675C Antibiotic carbapenem derivatives |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2066221C Conjugate vaccine for group b streptococcus |
| 07/22/2002 | WO2002057760A1 Method of detecting substance inhibiting type iii secretion mechanism of bacterium and the function of secretory protein tbereof |
| 07/22/2002 | CA2369373A1 A method for detecting substances inhibiting the bacterial type iii secretion mechanism and function of secretory proteins thereof |
| 07/18/2002 | WO2002055697A2 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055675A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055554A2 Antimicrobial peptides and derived metapeptides |
| 07/18/2002 | WO2002055545A1 Antimicrobial pseudopeptides |
| 07/18/2002 | WO2002055542A2 Hpv-specific peptides, which block the binding of hpv to the host cell |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055523A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055490A2 Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 07/18/2002 | WO2002055481A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055104A2 Acne vaccine |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055090A1 Preventives for microbial infections |
| 07/18/2002 | WO2002055088A1 Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
| 07/18/2002 | WO2002055087A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 07/18/2002 | WO2002055085A2 Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 07/18/2002 | WO2002055080A2 Method of immunomodulation using thione-forming disulfides |
| 07/18/2002 | WO2002055079A2 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055059A2 Method for preparing submicron particle suspensions |
| 07/18/2002 | WO2002055056A2 Local use of essential oils for treating herpes labialis |
| 07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | WO2002055022A2 Active metabolite of antifungal compound |
| 07/18/2002 | WO2002055015A2 Rapid antibiotic susceptibility test |
| 07/18/2002 | WO2002054931A2 Alpha-aminoboronic acids prepared by novel synthetic methods |
| 07/18/2002 | WO2002054868A2 Pulmonary delivery of polyene antifungal agents |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002030458A8 Yersinia adhesion protein as vaccine adjuvant |
| 07/18/2002 | WO2002022558A3 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/18/2002 | WO2002013856A3 W/o emulsion adjuvant compositions for vaccines |
| 07/18/2002 | WO2002012249A3 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 07/18/2002 | WO2002008198A3 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002004020A3 Pathogen resistance in organisms |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001079273A3 Viruses comprising mutated ion channel protein |
| 07/18/2002 | WO2001078789A3 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001068142A9 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2001045679A3 Use of chemotherapeutic agents for topical treatment |
| 07/18/2002 | WO2001037869A9 Vaccine compositions |
| 07/18/2002 | WO2001012668A9 Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | US20020095033 Monocyclic L-nucleosides, analogs and uses thereof |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094963 Benzimidazole derivatives |
| 07/18/2002 | US20020094961 Derivatives of polyene macrolides and preparation and use thereof |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094952 Human therapeutic uses of BPI Protein products |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | US20020094338 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 07/18/2002 | US20020094337 Prevention of recurrent viral disease |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | US20020094323 Administration of reactive oxygen species inhibitor or scavenger and at least one monocyte maturation-promoting agent |
| 07/18/2002 | DE10102050A1 Food, nutritional supplement, feed or medicament preparations containing conjugated cis/trans-octatrienoic acid, useful e.g. for reducing food intake, improving food utilization or treating cancer or diabetes |
| 07/18/2002 | DE10102048A1 Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer |
| 07/18/2002 | DE10100809A1 Verwendung von ätherischen Ölen zur topischen Behandlung von viralen Hauterkrankungen Use of essential oils for topical treatment of viral skin diseases |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2434793A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | CA2434573A1 Agent for protection against microorganism infection |
| 07/18/2002 | CA2434399A1 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |